BVMF/K1YS34 (BVMF/K1YS34)

Brazil Stock Exchange: BVMF/K1YS34 · BRL

R$56.7

+4.60 (+8.8%)· Recorded snapshot

Market cap	51.1B
Revenue (ttm)	2.3B
Net income (ttm)	1.3B
EPS (ttm)	R$1.44
P/E (trailing)	39.5x
P/E (forward)	34.7x
Volume	900

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.3B
Net income (ttm): 1.3B
EPS (ttm): R$1.44
P/E (trailing): 39.5x
P/E (forward): 34.7x
Market cap: 51.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E34.7

P25 n/aP50 n/aP75 n/a

Trailing P/E39.5

P25 n/aP50 n/aP75 n/a

ROE20.1

P25 n/aP50 n/aP75 n/a

ROIC40.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/K1YS34 indicators

Market & fundamental data

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-02
Employees	295
Employees change	20
Employees growth	7.27%
Enterprise value	BRL 45.2B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-10-25
Fiscal year end	December
Founded	2016
Industry	Biotechnology
Is primary listing	No
ISIN number	BRK1YSBDR003
Last refreshed	2026-10-29
Market cap	BRL 51.1B
Next earnings date	2026-11-02
Price	BRL 56.70
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	bvmf/K1YS34
Website	https://www.krystalbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	74.23x
Earnings yield	2.53%
EV/Earnings	36.16x
EV/EBIT	42.58x
EV/EBITDA	41.87x
EV/FCF	33.87x
EV/Sales	19.11x
FCF / EV yield	2.95%
FCF yield	2.61%
Forward P/E	34.68x
Graham number	15.61575
Graham upside	-72.46%
P/(FCF - SBC) ratio	48.58x
P/(OCF - SBC) ratio	45.33x
P/B ratio	7.26x
P/E ratio	39.5x
P/FCF ratio	38.27x
P/OCF ratio	36.23x
P/S ratio	22.4x
Price / tangible book value	7.26x
Price/EBITDA ratio	49.51x
Sector forward P/E	11.07x
Sector P/E	40.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	44.89%
EBITDA margin	45.24%
FCF margin	56.09%
Gross margin	94.64%
Operating margin	44.89%
Pretax margin	51.45%
Profit margin	54.82%
Profit per employee	BRL 4.2M
Profitable quarters	12
Profitable years	3
Revenue per employee	BRL 7.7M
ROA	9.37%
ROA (5Y)	-3.12%
ROCE	14.4%
ROE	20.12%
ROE (5Y)	-1.97%
ROIC	40.16%
ROIC (5Y)	-23.48%
SBC / revenue	12.41%
Tax / revenue	-3.37%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	62.4%
EPS growth (Q)	38.76%
EPS growth (QoQ)	-2.19%
EPS growth quarters	7
EPS growth years	3
FCF growth	39.01%
FCF growth (Q)	40.14%
FCF growth (QoQ)	-2.74%
Gross profit growth	24.3%
Gross profit growth (Q)	26.9%
Net income growth	64.57%
Net income growth (Q)	42.87%
Net income growth (QoQ)	-2.08%
Net income growth quarters	7
Net income growth years	3
OCF growth	39.38%
OCF growth (Q)	41.84%
OCF growth (QoQ)	-6.96%
Operating income growth	30.08%
Operating income growth (Q)	48.27%
Revenue growth	22.63%
Revenue growth (Q)	24.14%
Revenue growth (QoQ)	2.46%
Revenue growth quarters	8
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -75.4M
Depreciation and amortization	BRL 8.3M
EBIT	BRL 1B
EBITDA	BRL 1B
EPS	BRL 1.44
Financing cash flow	BRL 124.2M
Free cash flow	BRL 1.3B
Free cash flow minus SBC	BRL 1.1B
Gross profit	BRL 2.2B
Income taxes	BRL -76.9M
Investing cash flow	BRL -1.1B
Net cash flow	BRL 382.9M
Net income	BRL 1.3B
Operating cash flow minus SBC	BRL 1.1B
Operating income	BRL 1B
Revenue	BRL 2.3B
Stock-based compensation	BRL 283.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	30.07
Book value per share	BRL 237.92
Debt / EBITDA	0.04
Debt / equity	0.01
Debt / FCF	0.03
Long-term assets	BRL 2B
Long-term liabilities	BRL 44.5M
Net cash (debt)	BRL 5.7B
Net cash / market cap	11.09%
Net cash growth	34.89%
Net debt / EBITDA	-5.49
Net debt / equity	-0.8
Net debt / FCF	-4.24
Piotroski F-Score	5
Property, plant and equipment	BRL 868.1M
Shareholders' equity	BRL 7B
Tangible book value	BRL 7B
Tangible book value per share	BRL 237.92
Total assets	BRL 7.8B
Total cash	BRL 4.4B
Total debt	BRL 45.9M
Total liabilities	BRL 733.2M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.33
Current assets	BRL 5.7B
Current liabilities	BRL 688.7M
Current ratio	8.32
Inventory turnover	0.62
Net working capital	BRL 458.1M
Quick ratio	7.73
Working capital	BRL 4.8B
Working capital turnover	2.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.46%
Shareholder yield	-1.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	8.83%
52-week high	BRL 56.70
52-week high date	2026-10-27
52-week low	BRL 44.80
52-week low date	2026-03-26
6M price change	26.56%
6M total return	26.56%
All-time high	BRL 56.70
All-time high date	2026-10-27
All-time low	BRL 44.80
All-time low date	2026-03-26
Average volume	2.5K
Change from 52-week high	0%
Change from 52-week low	26.56%
Change from all-time high	0%
Change from all-time low	26.56%
Change from open	0%
Day's gap	8.83%
Dollar volume	BRL 51,030
High price	BRL 56.70
Low price	BRL 56.70
Monthly RSI	0
Open price	BRL 56.70
Previous close	BRL 52.10
Relative volume	0.36
RSI	0
Sharpe ratio	53.36
Volume	900
Weekly RSI	0

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	23.6M
Shares change (QoQ)	0.49%
Shares change (YoY)	1.46%
Shares held by insiders	9.94%
Shares held by institutions	89.75%
Short ratio	10.6 days

Deeper analysis on BVMF/K1YS34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/K1YS34 report

Is a complete BVMF/K1YS34 research report available?

No complete published report is available for bvmf/K1YS34 (BVMF/K1YS34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/K1YS34 (BVMF/K1YS34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/K1YS34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/K1YS34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/K1YS34

Frequently asked questions